RIPK2 and cardiac hypertrophy: Further research indicated that RIPK2 can interact with MAVS in cardiomyocytes via CARD-CARD domain interactions, promoting NF-κB signaling, which leads to inflammation and myocardial hypertrophy (Lin et al., 2020).